• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

乳腺癌中 GASC1 组蛋白去甲基化酶基因的基因组扩增和致癌特性。

Genomic amplification and oncogenic properties of the GASC1 histone demethylase gene in breast cancer.

机构信息

Department of Pathology, Breast Cancer Program, Karmanos Cancer Institute, Wayne State University, Detroit, MI 48201, USA.

出版信息

Oncogene. 2009 Dec 17;28(50):4491-500. doi: 10.1038/onc.2009.297. Epub 2009 Sep 28.

DOI:10.1038/onc.2009.297
PMID:19784073
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2795798/
Abstract

Earlier, mapping of the 9p23-24 amplicon in esophageal cancer cell lines led us to the positional cloning of gene amplified in squamous cell carcinoma 1 (GASC1), which encodes a nuclear protein with a Jumonji C domain that catalyzes lysine (K) demethylation of histones. However, the transforming roles of GASC1 in breast cancer remain to be determined. In this study, we identified GASC1 as one of the amplified genes for the 9p23-24 region in breast cancer, particularly in basal-like subtypes. The levels of GASC1 transcript expression were significantly higher in aggressive, basal-like breast cancers compared with nonbasal-like breast cancers. Our in vitro assays demonstrated that GASC1 induces transformed phenotypes, including growth factor-independent proliferation, anchorage-independent growth, altered morphogenesis in Matrigel, and mammosphere forming ability, when overexpressed in immortalized, nontransformed mammary epithelial MCF10A cells. Additionally, GASC1 demethylase activity regulates the expression of genes critical for stem cell self-renewal, including NOTCH1, and may be linked to the stem cell phenotypes in breast cancer. Thus, GASC1 is a driving oncogene in the 9p23-24 amplicon in human breast cancer and targeted inhibition of GASC1 histone demethylase in cancer could provide potential new avenues for therapeutic development.

摘要

早些时候,我们在食管癌细胞系中对 9p23-24 扩增子进行了作图,导致我们对鳞状细胞癌 1 中基因扩增(GASC1)进行了定位克隆,该基因编码一种具有 Jumonji C 结构域的核蛋白,该结构域可催化组蛋白赖氨酸(K)去甲基化。然而,GASC1 在乳腺癌中的转化作用仍有待确定。在这项研究中,我们确定 GASC1 是乳腺癌 9p23-24 区域扩增基因之一,特别是在基底样亚型中。与非基底样乳腺癌相比,GASC1 转录物表达水平在侵袭性、基底样乳腺癌中显著升高。我们的体外实验表明,当在永生化、非转化的乳腺上皮 MCF10A 细胞中过表达时,GASC1 可诱导转化表型,包括生长因子非依赖性增殖、无锚定生长、Matrigel 中形态发生改变和乳腺球形成能力。此外,GASC1 去甲基酶活性调节包括 NOTCH1 在内的对干细胞自我更新至关重要的基因的表达,并且可能与乳腺癌中的干细胞表型有关。因此,GASC1 是人类乳腺癌 9p23-24 扩增子中的驱动癌基因,针对 GASC1 组蛋白去甲基酶的靶向抑制可能为癌症治疗开发提供新的途径。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2961/2795798/19c39808931e/nihms141654f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2961/2795798/cadd16faeee9/nihms141654f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2961/2795798/f233ae54b3c0/nihms141654f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2961/2795798/8cb22564ee5e/nihms141654f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2961/2795798/140fc73e6071/nihms141654f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2961/2795798/aeeb6393714d/nihms141654f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2961/2795798/19c39808931e/nihms141654f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2961/2795798/cadd16faeee9/nihms141654f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2961/2795798/f233ae54b3c0/nihms141654f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2961/2795798/8cb22564ee5e/nihms141654f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2961/2795798/140fc73e6071/nihms141654f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2961/2795798/aeeb6393714d/nihms141654f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2961/2795798/19c39808931e/nihms141654f6.jpg

相似文献

1
Genomic amplification and oncogenic properties of the GASC1 histone demethylase gene in breast cancer.乳腺癌中 GASC1 组蛋白去甲基化酶基因的基因组扩增和致癌特性。
Oncogene. 2009 Dec 17;28(50):4491-500. doi: 10.1038/onc.2009.297. Epub 2009 Sep 28.
2
Identification and functional analysis of 9p24 amplified genes in human breast cancer.鉴定和功能分析 9p24 扩增基因在人类乳腺癌。
Oncogene. 2012 Jan 19;31(3):333-41. doi: 10.1038/onc.2011.227. Epub 2011 Jun 13.
3
Identification of a novel gene, GASC1, within an amplicon at 9p23-24 frequently detected in esophageal cancer cell lines.在9p23 - 24扩增子内鉴定出一个新基因GASC1,该扩增子在食管癌细胞系中经常被检测到。
Cancer Res. 2000 Sep 1;60(17):4735-9.
4
The oncogenic role of GASC1 in chemically induced mouse skin cancer.GASC1在化学诱导的小鼠皮肤癌中的致癌作用。
Mamm Genome. 2015 Dec;26(11-12):591-7. doi: 10.1007/s00335-015-9592-9. Epub 2015 Aug 7.
5
Histone Demethylase GASC1 Inhibitor Targeted GASC1 Gene to Inhibit the Malignant Transformation of Esophageal Cancer through the NOTCH-MAPK Signaling Pathway.组蛋白去甲基化酶GASC1抑制剂靶向GASC1基因通过NOTCH-MAPK信号通路抑制食管癌的恶性转化。
Ann Clin Lab Sci. 2022 Mar;52(2):240-248.
6
A novel amplicon at 9p23 - 24 in squamous cell carcinoma of the esophagus that lies proximal to GASC1 and harbors NFIB.食管鳞状细胞癌中位于GASC1近端且含有NFIB的9p23 - 24处的一个新扩增子。
Jpn J Cancer Res. 2001 Apr;92(4):423-8. doi: 10.1111/j.1349-7006.2001.tb01112.x.
7
Histone demethylase GASC1--a potential prognostic and predictive marker in invasive breast cancer.组蛋白去甲基化酶 GASC1 是浸润性乳腺癌的一个潜在的预后和预测标志物。
BMC Cancer. 2012 Nov 14;12:516. doi: 10.1186/1471-2407-12-516.
8
GASC1 promotes glioma progression by enhancing NOTCH1 signaling.GASC1 通过增强 NOTCH1 信号促进神经胶质瘤进展。
Mol Med Rep. 2021 May;23(5). doi: 10.3892/mmr.2021.11949. Epub 2021 Mar 2.
9
The putative oncogene GASC1 demethylates tri- and dimethylated lysine 9 on histone H3.假定的癌基因GASC1可使组蛋白H3上的赖氨酸9发生三甲基化和二甲基化去甲基化。
Nature. 2006 Jul 20;442(7100):307-11. doi: 10.1038/nature04837. Epub 2006 May 28.
10
Post-Transcriptional Regulation of the GASC1 Oncogene with Active Tumor-Targeted siRNA-Nanoparticles.活性肿瘤靶向性小干扰RNA纳米颗粒对癌基因GASC1的转录后调控
Mol Pharm. 2016 Aug 1;13(8):2605-21. doi: 10.1021/acs.molpharmaceut.5b00948. Epub 2016 Jun 27.

引用本文的文献

1
Mutation of the histone demethylase Gasc1 causes ASD-like symptoms in mice.组蛋白去甲基化酶Gasc1的突变在小鼠中引发类似自闭症谱系障碍的症状。
Inflamm Regen. 2025 Jul 9;45(1):22. doi: 10.1186/s41232-025-00374-5.
2
KDM4C inhibition blocks tumor growth in basal breast cancer by promoting cathepsin L-mediated histone H3 cleavage.KDM4C抑制通过促进组织蛋白酶L介导的组蛋白H3切割来阻断基底样乳腺癌的肿瘤生长。
Nat Genet. 2025 Jun 2. doi: 10.1038/s41588-025-02197-z.
3
USP35 promotes hepatocellular carcinoma proliferation through GASC1-mediated ROCK2 upregulation.

本文引用的文献

1
Multiple recurrent genetic events converge on control of histone lysine methylation in medulloblastoma.多种复发性遗传事件共同作用于髓母细胞瘤中组蛋白赖氨酸甲基化的调控。
Nat Genet. 2009 Apr;41(4):465-72. doi: 10.1038/ng.336. Epub 2009 Mar 8.
2
Mucosa-associated lymphoid tissue lymphoma: novel translocations including rearrangements of ODZ2, JMJD2C, and CNN3.黏膜相关淋巴组织淋巴瘤:新型易位,包括ODZ2、JMJD2C和CNN3的重排。
Clin Cancer Res. 2008 Oct 15;14(20):6426-31. doi: 10.1158/1078-0432.CCR-08-0702.
3
Rational targeting of Notch signaling in cancer.
USP35通过GASC1介导的ROCK2上调促进肝细胞癌增殖。
Transl Oncol. 2025 Aug;58:102430. doi: 10.1016/j.tranon.2025.102430. Epub 2025 May 26.
4
The role of histone post-translational modifications in cancer and cancer immunity: functions, mechanisms and therapeutic implications.组蛋白翻译后修饰在癌症及癌症免疫中的作用:功能、机制及治疗意义
Front Immunol. 2024 Nov 15;15:1495221. doi: 10.3389/fimmu.2024.1495221. eCollection 2024.
5
Targeting N-Methyl-lysine Histone Demethylase KDM4 in Cancer: Natural Products Inhibitors as a Driving Force for Epigenetic Drug Discovery.靶向癌症中的N-甲基赖氨酸组蛋白去甲基化酶KDM4:天然产物抑制剂作为表观遗传药物发现的驱动力
ChemMedChem. 2025 Feb 16;20(4):e202400682. doi: 10.1002/cmdc.202400682. Epub 2024 Nov 21.
6
Identification of as a gene conferring drug resistance in multiple myeloma.鉴定某基因作为多发性骨髓瘤中赋予耐药性的基因。 (你提供的原文中“Identification of as”表述不完整,这里是按照合理推测补充完整后的翻译)
Open Life Sci. 2024 Apr 12;19(1):20220848. doi: 10.1515/biol-2022-0848. eCollection 2024.
7
The emerging roles of histone demethylases in cancers.组蛋白去甲基化酶在癌症中的新兴作用。
Cancer Metastasis Rev. 2024 Jun;43(2):795-821. doi: 10.1007/s10555-023-10160-9. Epub 2024 Jan 16.
8
Chromatin-modifying enzymes as modulators of nuclear size during lineage differentiation.染色质修饰酶作为谱系分化过程中核大小的调节因子。
Cell Death Discov. 2023 Oct 20;9(1):384. doi: 10.1038/s41420-023-01639-z.
9
KDM4 Demethylases: Structure, Function, and Inhibitors.KDM4去甲基化酶:结构、功能及抑制剂
Adv Exp Med Biol. 2023;1433:87-111. doi: 10.1007/978-3-031-38176-8_5.
10
Targeting Histone 3 Variants Epigenetic Landscape and Inhibitory Immune Checkpoints: An Option for Paediatric Brain Tumours Therapy.靶向组蛋白 3 变体表观遗传景观和抑制性免疫检查点:小儿脑肿瘤治疗的一种选择。
Curr Neuropharmacol. 2024;22(7):1248-1270. doi: 10.2174/1570159X21666230809110444.
癌症中Notch信号通路的合理靶向治疗
Oncogene. 2008 Sep 1;27(38):5124-31. doi: 10.1038/onc.2008.226.
4
An embryonic stem cell-like gene expression signature in poorly differentiated aggressive human tumors.低分化侵袭性人类肿瘤中的胚胎干细胞样基因表达特征
Nat Genet. 2008 May;40(5):499-507. doi: 10.1038/ng.127.
5
DNA copy number alterations and expression of relevant genes in triple-negative breast cancer.三阴性乳腺癌中的DNA拷贝数改变及相关基因的表达
Genes Chromosomes Cancer. 2008 Jun;47(6):490-9. doi: 10.1002/gcc.20550.
6
MLL translocations, histone modifications and leukaemia stem-cell development.混合谱系白血病(MLL)易位、组蛋白修饰与白血病干细胞发育
Nat Rev Cancer. 2007 Nov;7(11):823-33. doi: 10.1038/nrc2253.
7
Jmjd1a and Jmjd2c histone H3 Lys 9 demethylases regulate self-renewal in embryonic stem cells.Jmjd1a和Jmjd2c组蛋白H3赖氨酸9去甲基化酶调控胚胎干细胞的自我更新。
Genes Dev. 2007 Oct 15;21(20):2545-57. doi: 10.1101/gad.1588207.
8
Gene expression profiling and histopathological characterization of triple-negative/basal-like breast carcinomas.三阴性/基底样乳腺癌的基因表达谱分析与组织病理学特征
Breast Cancer Res. 2007;9(5):R65. doi: 10.1186/bcr1771.
9
Mammary stem cells and breast cancer--role of Notch signalling.乳腺干细胞与乳腺癌——Notch信号通路的作用
Stem Cell Rev. 2007 Jun;3(2):169-75. doi: 10.1007/s12015-007-0023-5.
10
Comparative integromics on JMJD2A, JMJD2B and JMJD2C: preferential expression of JMJD2C in undifferentiated ES cells.JMJD2A、JMJD2B和JMJD2C的比较整合基因组学研究:JMJD2C在未分化胚胎干细胞中的优先表达。
Int J Mol Med. 2007 Aug;20(2):269-73.